AI drug development

Researcher looking at an iPad
Pfizer, Tempus collaborate on cancer drug development
By Jessica Hagen | 11:49 am | March 02, 2023
The multinational pharma company will access Tempus' AI-enabled data library to further therapeutic development and advance its portfolio in oncology.